Bioethics International’s (BEI) mission is to empower professionals and organizations in healthcare, life science and biotechnology to make responsible decisions – on issues that impact patients the most. Currently, we focus on the ethics and governance of how medicines are researched, developed, marketed and made accessible to patients around the world. Our main project, the "Good Pharma Scorecard" (GPS), is an Index that ranks the 20 largest pharma and biotech companies and new drugs on their ethics and transparency performance. Our first GPS scorecard ranked companies and new drugs on their R&D and clinical trial transparency performance.